Your session is about to expire
← Back to Search
Fitbit Program for Cancer Survivors
N/A
Waitlist Available
Led By Cindy K Blair, PhD
Research Sponsored by University of New Mexico
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 1-year
Awards & highlights
Study Summary
This trial helps cancer survivors increase activity through a home-based program with a Fitbit and health coaching.
Who is the study for?
This trial is for older cancer survivors in New Mexico who've finished primary treatment and aren't currently being treated for recurrence. They should have mild-to-moderate physical impairment, be able to walk without assistance, own or use a provided smartphone with internet access weekly, and do less than 120 minutes of moderate exercise per week. Those with severe impairments or medical conditions preventing light activity, working over 20 hours a week, or involved in other activity programs are excluded.Check my eligibility
What is being tested?
The MY Health Pilot Study tests if using a Fitbit tracker along with health coaching can increase daily light physical activity among older cancer survivors. It's a home-based study lasting 12 weeks where participants will either receive the intervention or not by chance.See study design
What are the potential side effects?
Since this trial involves light physical activities monitored by Fitbit and health coaching rather than medication, side effects may include typical risks associated with increasing physical activity such as muscle soreness or strain.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 1-year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 1-year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Number of adverse events attributable to the study
Study participant adherence rate
Study participant retention rate
+1 moreOther outcome measures
Change in balance score during the 4-stage balance test.
Change in fall risk
Change in motivation
+16 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Experimental: Immediate Fitbit InterventionExperimental Treatment1 Intervention
Participants randomized to this arm receive the 12-week Fitbit intervention; participants then crossover and are observed (no health coaching) for an additional 12-weeks. The Fitbit intervention includes a Fitbit activity tracker, the free Fitbit smartphone app, and 6 Health Coaching calls.
Group II: Comparator: Delayed Fitbit InterventionActive Control1 Intervention
Wait-listed; participants maintain their usual physical activity for 12-weeks; participants then crossover and receive the full 12-week Fitbit intervention.
Find a Location
Who is running the clinical trial?
University of New MexicoLead Sponsor
372 Previous Clinical Trials
3,528,725 Total Patients Enrolled
2 Trials studying Cancer Survivors
63 Patients Enrolled for Cancer Survivors
National Cancer Institute (NCI)NIH
13,657 Previous Clinical Trials
40,933,603 Total Patients Enrolled
70 Trials studying Cancer Survivors
17,487 Patients Enrolled for Cancer Survivors
Cindy K Blair, PhDPrincipal InvestigatorUniversity of New Mexico
2 Previous Clinical Trials
63 Total Patients Enrolled
2 Trials studying Cancer Survivors
63 Patients Enrolled for Cancer Survivors
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I can walk 3 blocks without help or needing to rest.I work or volunteer for more than 20 hours a week.I am unable to give consent for myself.I can speak, read, and understand English or Spanish.I have severe difficulties with seeing or hearing, or I cannot do light physical activities due to other health issues.I can have someone with me for safety during remote physical tests.I have some difficulty with daily physical activities.I was diagnosed with cancer in New Mexico, finished my main treatment, and am not currently being treated for cancer coming back. I can join if my doctor agrees, even if my cancer has spread.
Research Study Groups:
This trial has the following groups:- Group 1: Experimental: Immediate Fitbit Intervention
- Group 2: Comparator: Delayed Fitbit Intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any opportunities currently available for participants to join this experiment?
"As demonstrated by the clinicaltrials.gov website, this trial is open for new participants. Originally posted on November 4th 2022 and last updated on November 23rd 2022; this research programme seeks more applicants."
Answered by AI
What is the participant cap for this investigation?
"Affirmative. According to the information available on clinicaltrials.gov, this medical study is currently enrolling participants; with its initial posting date being November 4th 2022 and the latest update occurring on November 23rd 2022. A total of 64 individuals need to be recruited from a single site."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger